SCHEMBL5999764

SCHEMBL5999764

NC(=O)c1ccc(COc2ccccc2)cc1

nearest known ligand 0.87

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 8/20 0.87
MAOB P27338 4/20 0.71
ALDH1A1 P00352 1/20 0.71
MAPT P10636 1/20 0.71
PARP1 P09874 1/20 0.64
NR4A1 P22736 1/20 0.64
NR4A2 P43354 1/20 0.64
NR4A3 Q92570 1/20 0.64
MEN1 O00255 1/20 0.62
NPC1 O15118 1/20 0.62
RAB9A P51151 1/20 0.62
KMT2A Q03164 1/20 0.62
RXFP1 Q9HBX9 1/20 0.62
FFAR1 O14842 1/20 0.60
PLA2G10 O15496 1/20 0.59
PLA2G2A P14555 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL119689 0.93 PARP10 (1.00) PARP10MAOBNR4A1NR4A2NR4A3
Hydrochloric Acid SCHEMBL8861530 0.91 PARP10 (0.97) PARP10MAOBALDH1A1MAPTNR4A1
SCHEMBL1750167 0.85 NR4A2 (0.86) ALDH1A1MAPTNR4A1NR4A2NR4A3
SCHEMBL11117974 0.83 PARP10 (0.83) PARP10MAOBALDH1A1MAPTNR4A2
SCHEMBL12339549 0.83 PARP10 (0.83) PARP10MAOBALDH1A1MAPTPARP1
SCHEMBL13513249 0.82 MAOB (0.87) MAOBALDH1A1MAPTNR4A1NR4A2
SCHEMBL1387246 0.81 NR4A2 (0.77) PARP10MAOBNR4A2MEN1KMT2A
SCHEMBL19980221 0.81 F10 (0.72) PARP10MAOBNR4A2RAB9ARXFP1
SCHEMBL4338622 0.81 MAOB (0.74) PARP10MAOBNR4A2
SCHEMBL14533430 0.81 PARP10 (0.63) PARP10MAOBALDH1A1MAPTPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060047123-A1 Mercaptoamides as histone deacetylase inhibitors AHMED SALEH 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047123-A1 Mercaptoamides as histone deacetylase inhibitors HDAC1, HDAC11, HDAC2 PARP10 1205/4885MAOB 870/4885ALDH1A1 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.